TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/08/2025
Back to search
Official data from USPTO
HTL BIOTECHNOLOGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
04/03/2026
Trademark type
Combined
Nice classes
1, 3, 5, 42
Filing date
06/02/2022
Registration date
04/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/02/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
34
Owner location
FR
Examiner
BARRETT, LEAH N
Law office
L60
Current location
TMEG LAW OFFICE 106
Mark description
The mark consists of the stylized blue lettering "HTL" above the green wording "BIOTECHNOLOGY". To the left of the wording, strands of DNA, one blue and one green, are drawn. The color white represents background and is not part of the mark.
Holders and representatives
Holders
H.T.L
Representatives
Philip Conrad Decode Legal Inc.
Technical classification
Nice Classes
Class 1Class 3Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and science; chemical raw materials in the nature of biopolymers for use in industry and science
Class 3
Cosmetic preparations for skin careskin tanningfor slimming purposes; cosmetic preparations for nailhair and teeth care
Class 5
Pharmaceutical and veterinary preparationspharmaceutical preparations for the treatment of dermatologicalrheumatologicalophthalmological diseasesdisorders and conditionsfor use in regenerative medicine and for treatment or augmentation of bone and tissue; chemical preparations for medical and veterinary usefor the treatment of dermatologicalrheumatologicalophthalmological diseasesdisorders and conditionsfor use in regenerative medicine and for treatment or augmentation of bone and tissue
Class 42
Industrial analysis and research in the field of pharmaceutical productshealthcare productscosmetic products and medical devices containing hyaluronic acid and derivativesother biopolymers of medical or cosmetic interest; research and development of new products for third parties
Publications
History of USPTO decisions and trademark events.
35 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/08/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/08/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/02/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/16/2024
FIMP
FINAL DISPOSITION PROCESSED
10/16/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/03/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/02/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/29/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/16/2024
PUBO
PUBLISHED FOR OPPOSITION
01/16/2024
GPNX
NOTIFICATION PROCESSED BY IB
01/13/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/10/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/10/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/27/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/27/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/11/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
12/11/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/11/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
12/11/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/07/2023
RFNP
REFUSAL PROCESSED BY IB
05/31/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/11/2023
RFRR
REFUSAL PROCESSED BY MPU
05/10/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/22/2023
CNRT
NON-FINAL ACTION WRITTEN
03/21/2023
DOCK
ASSIGNED TO EXAMINER
03/20/2023
MAFR
APPLICATION FILING RECEIPT MAILED
08/09/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/05/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/04/2022
Continuous trademark protection
Get notified about every new filing that threatens HTL BIOTECHNOLOGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.